Brief: Aurobindo Pharma Says Theranym Biologics Announces Additional Product Schedule With MSD
15/04/2026 11:32
April 15 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: AUROBINDO PHARMA - THERANYM BIOLOGICS ANNOUNCES ADDITIONAL PRODUCT SCHEDULE WITH MSD AUROBINDO PHARMA - THERANYM TO BUILD DRUG SUBSTANCE FACILITY WITH 60 KL BIOREACTOR CAPACITY AUROBINDO PHARMA - THERANYM TO INVEST USD 150-175 MILLION IN MANUFACTURING FACILITY Source text: ID:nBSEb22ZnT Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11